Monitoring of plasma and urine tumor-derived DNA to inform bladder-sparing approaches for patients with muscle-invasive bladder cancer. - Galsky MD; Izadmehr S; Yu M; Curtis SD; Douville C; Popoli M; Ptak J; Dobbyn L; Silliman N; Chan KG; Dorff TB; Cetnar JP; et al. (Proceedings of the National Academy of Sciences of the United States of America, 2026)